This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast

This study has been terminated.
(Funding ended)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Georgetown University Identifier:
First received: May 9, 2009
Last updated: April 6, 2016
Last verified: January 2015

RATIONALE: Studying samples of breast tissue in the laboratory may help doctors learn more about the genes and proteins found in breast tissue.

PURPOSE: This phase I trial is studying genes and proteins in breast tissue from women undergoing surgery for breast cancer or core biopsy of the breast.

Condition Intervention Phase
Breast Cancer Genetic: microarray analysis Procedure: breast biopsy Phase 1

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Pilot Study for Analysis of Tumor Gene Expression by DNA Microarray Analysis in Patients Undergoing Breast Cancer Surgery or Core Biopsy Sampling

Resource links provided by NLM:

Further study details as provided by Georgetown University:

Primary Outcome Measures:
  • Tumor gene expression as assessed by DNA microarray analysis [ Time Frame: 1 year ]
    tumor sample will be assessed by DNA microarray

Enrollment: 100
Study Start Date: September 1999
Estimated Study Completion Date: December 2016
Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Intervention Details:
    Genetic: microarray analysis
    tumor specimen will be assessed by microarray analysis
    Procedure: breast biopsy
    A breast biopsy will be done to obtain a tumor specimen
Detailed Description:


  • Assess tumor gene expression information from women undergoing surgery for breast cancer or core biopsy sampling of the breast.

OUTLINE: This is a pilot study.

Tumor tissue is collected and analyzed for tumor gene expression by DNA microarray analysis for research studies.

PROJECTED ACCRUAL: A total of 100 patients will be accrued for this study.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Any woman undergoing a breast biopsy or breast surgery


  • Undergoing surgery for breast cancer OR core biopsy sampling of the breast


  • Not specified


  • Not specified
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00898937

United States, District of Columbia
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington, District of Columbia, United States, 20007
Sponsors and Collaborators
Georgetown University
National Cancer Institute (NCI)
Principal Investigator: Claudine Isaacs, MD Lombardi Comprehensive Cancer Center
  More Information

Responsible Party: Georgetown University Identifier: NCT00898937     History of Changes
Other Study ID Numbers: CDR0000377341
P50CA058185 ( US NIH Grant/Contract Award Number )
P30CA051008 ( US NIH Grant/Contract Award Number )
Study First Received: May 9, 2009
Last Updated: April 6, 2016

Keywords provided by Georgetown University:
breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases processed this record on June 23, 2017